Acumen Pharmaceuticals, Inc. (ABOS)
2.13
+0.17
(+8.67%)
USD |
NASDAQ |
Dec 12, 16:00
2.13
0.00 (0.00%)
After-Hours: 16:11
Acumen Pharmaceuticals EPS Diluted (Quarterly): -0.4367 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Black Diamond Therapeutics, Inc. | -0.1493 |
| Pulmonx Corp. | -0.3409 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.45M |
| Total Expenses (Quarterly) | 26.45M |
| Enterprise Value | 22.95M |
| Earnings Yield | -103.6% |
| Normalized Earnings Yield | -103.75 |